Skip to main content
Equibles

MetLife Investment Management, LLC

Position in MGNX — Macrogenics Inc

CIK 1529735 Whippany, NJ
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$172,529
+$162,794 QoQ
Shares Held
37,344
+387.1% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. MGNX ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in MGNX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $172,529 37,344
2025-03-31 $9,735 7,666
2024-12-31 $128,924 39,669
2024-09-30 $49,655 15,093
2024-06-30 $151,091 35,551
2024-03-31 $488,394 33,179
2023-12-31 $319,181 33,179
2023-09-30 $154,614 33,179
2023-06-30 $177,507 33,179
2023-03-31 $237,893 33,179
2022-12-31 $222,631 33,179
2022-09-30 $114,799 33,179
2022-06-30 $13,968 4,735
2022-03-31 $293,602 33,326
2021-12-31 $337,996 21,059
2021-09-30 $440,975 21,059
2021-06-30 $565,644 21,059
2021-03-31 $670,729 21,059
2020-12-31 $513,755 22,474
2020-09-30 $566,120 22,474
2020-06-30 $627,474 22,474
2020-03-31 $130,798 22,474